School of Life Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
Drugs Aging. 2010 Mar 1;27(3):239-54. doi: 10.2165/11532870-000000000-00000.
Adherence to medicines is a major determinant of their effectiveness. However, estimates of non-adherence in the older-aged (defined as those aged >or=65 years) with chronic conditions vary from 40% to 75%. The problems caused by non-adherence in the older-aged include residential care and hospital admissions, progression of the disease and increased costs to society. The reasons for non-adherence in the older-aged include items related to the medicine (e.g. cost, number of medicines, adverse effects) and those related to the person (e.g. cognition, vision, depression). It is also known that there are many ways adherence can be increased (e.g. use of blister packs, cues). Although it is assumed that interventions by allied health professionals (i.e. other than the prescriber/doctor), including a discussion of adherence, will improve adherence to medicines in the older-aged, the evidence for this has not been reviewed. There is some evidence that telephone counselling concerning adherence by a nurse or pharmacist improves short- and long-term adherence. However, face-to-face intervention counselling at the pharmacy or during a home visit by a pharmacist has shown variable results, with some studies showing improved adherence and some not. Broad-based education programmes during hospital stays have not been shown to improve medication adherence following discharge, whereas education programmes specifically for subjects with hypertension have been shown to improve adherence. In combination with an education programme, both counselling and a medicine review programme have been shown to improve short-term adherence in the older-aged. Thus, there are many unanswered questions about the most effective interventions for promoting adherence. More studies are needed to determine the most appropriate interventions by allied health professionals, and such studies need to consider the disease state, demographics and socioeconomic status of the older-aged subject, and the intensity and duration of intervention required.
药物依从性是药物有效性的主要决定因素。然而,对于患有慢性病的老年人(定义为年龄≥65 岁的人群),药物不依从的估计值在 40%到 75%之间不等。老年人药物不依从会导致各种问题,包括入住养老院和住院治疗、疾病进展以及社会成本增加。老年人药物不依从的原因包括与药物相关的因素(例如费用、用药数量、不良反应)和与个人相关的因素(例如认知能力、视力、抑郁)。此外,人们还知道有很多方法可以提高药物依从性(例如使用泡罩包装、提示)。虽然人们认为除了开处方的医生/医生之外,其他医疗保健专业人员(即药师、护士等)进行的干预措施(包括讨论药物依从性)将改善老年人的药物依从性,但这方面的证据尚未得到审查。有一些证据表明,护士或药剂师通过电话咨询有关药物依从性的问题,可以改善短期和长期的药物依从性。然而,在药店进行面对面的干预咨询或由药剂师进行家访的效果则各不相同,一些研究表明药物依从性得到了改善,而另一些则没有。在住院期间开展广泛的教育计划并未显示可以改善出院后的药物依从性,而专门针对高血压患者的教育计划则显示可以提高药物依从性。将咨询和药物审查计划与教育计划相结合,已被证明可以改善老年人的短期药物依从性。因此,关于促进药物依从性最有效的干预措施,还有很多问题没有答案。需要开展更多的研究来确定医疗保健专业人员最适合的干预措施,这些研究需要考虑老年人的疾病状况、人口统计学和社会经济状况,以及所需干预的强度和持续时间。